FSBEI DPO Russian Medical Academy of Continuing Professional Education of the Ministry of Health of Russia Information Center on Pharmacotherapy in Patients with New Coronavirus Infection COVID-19 "PharmaCOVID" on the basis of the FGBOU DPO RMANPO of the Ministry of Health of Russia for healthcare professionals Materials based on the results of processing requests from medical organizations "PharmaCovid" Corresponding Member of the Russian Academy of Sciences, Professor of the Russian Academy of Sciences, Doctor of Medical Sciences, Rector of the Federal State Budgetary Educational Institution of Higher Professional Education RMANPO of the Ministry of Health of the Russian Federation Dmitry A. New materials based on the results of processing requests November 7, 2021 coronavirus infection (COVID-19) , systemic glucocorticoids , oxygen therapy Possibility of using glucocorticoids in inpatients with severe COVID-19 The answer was prepared by experts: V.M. Tsvetov, A.V. Matveev2, K.B. Mirzaev, V.A. Otdelnov, D.A. Sychev Log in to download the document https://pharmateca.ru/ru/archive/article/40893 August 13, 2021 coronavirus infection , COVID-19 , genetically engineered biological products The rationale for the combined use of genetically engineered biological drugs in patients with COVID-19 The answer was prepared by experts: I.S. Burashnikova Log in to download the document All results For full access to the materials, log in or register as a healthcare professional. Sign in Materials based on the results of processing requests from medical organizations About the Center Center experts Algorithm for processing requests Mobile applications A responsibility Cooperation Patient deprescribing COVID-19 Preprints ФармаCOVID на Интернисте Внести предложения по работе Центра: pharma-covid@rmapo.ru Материалы, в том числе ответы экспертов «Информационного центра по вопросам фармакотерапии у пациентов с новой коронавирусной инфекцией COVID-19 «ФармаCOVID», размещённые в информационно-телекоммуникационной сети «Интернет» на официальном сайте, носят рекомендательный характер, являются результатами интеллектуальной деятельности и находятся под защитой авторских прав. Any unauthorized borrowing, including the interpretation, copying of a part or the full text, distribution, including in any modified form with the addition of words, links, pictures, drawings, graphic images and other, disclosure (hereinafter in general, respectively - use) of the specified materials (information ) IT IS FORBIDDEN to be used for advertising purposes (advertising / advertising materials), both medicinal products and other means, without the prior consent of the copyright holder. The use of the result of intellectual activity, if such use is carried out without the consent of the copyright holder, is illegal and entails the responsibility established by the legislation of the Russian Federation. *Privacy Policy